We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Implantable Electrode Cuff Lowers Blood Pressure

By HospiMedica International staff writers
Posted on 27 May 2014
A prototype implantable cuff equipped with electrodes can help lower blood pressure (BP) without causing side effects.

The BaroLoop procedure developed by researchers at the University of Freiburg (Germany) takes advantage of the baroreflex homeostatic mechanism, which helps to maintain BP at nearly constant levels. More...
It does so by using a special cuff with 24 electrodes that is implanted in the vagal nerve (VN). The device works by first determining which of the electrodes is closest to the nerve fibers that transmit the BP signal. It then uses electrostimulation to overwrite the information in these fibers with such precision that other nearby bundles of nerve fibers (with other functions) are not affected.

The novel method for selective VN stimulation is based on true tripolar recording and a coherent averaging algorithm triggered by BP or electrocardiogram. In in-vivo experiments in rats, tripolar stimulation over electrodes near the baroreflex fibers reduced BP without triggering significant bradycardia and bradypnea. The BP drop was adjusted to 60% of the initial value by varying the stimulation pulse width and duration, and lasted up to five times longer than the stimulation. The study describing the BaroLoop procedure was published on May 8, 2014, in the Journal of Neural Engineering.

“The presented method is robust to impedance changes, independent of the electrode's relative position, does not compromise the nerve, and can run on implantable, ultra-low power signal processors,” concluded lead author microsystems engineers Dennis Plachta, PhD, of the department of microsystems engineering (IMTEK), and colleagues.

The baroreflex provides a rapid negative feedback loop in which an elevated BP reflexively causes the heart rate to decrease, causing BP to decrease. Decreased BP lowers baroreflex activation and causes the heart rate to increase and to restore BP levels. The baroreflex can begin to act in less than the duration of a cardiac cycle (fractions of a second). The system relies on specialized stretch receptor neurons known as baroreceptors in the aortic arch, carotid sinuses, and elsewhere to monitor changes in BP and relay them to the brainstem, which then mediates BP by both branches of the autonomic nervous system, the parasympathetic and sympathetic nerves.

Related Links:

University of Freiburg



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.